Literature DB >> 18473487

Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.

Deng-Long Wu1, Wen-Hong Zhang, Wen-Jing Wang, San-Bao Jing, Yue-Ming Xu.   

Abstract

There is no useful marker in screening and early diagnosis for renal cell carcinomas (RCCs), especially in the urine. To screen for specific markers in the urine of RCCs patients, surface enhanced laser desorption and ionization time of flight mass spectrometry (SELDI-TOF-MS) was used and coupled with a tree analysis pattern to develop SELDI protein profiling of urine. Urine samples from 58 RCC patients, 45 healthy volunteers, and 56 patients with other urogenital diseases were analyzed using IMAC-Cu ProteinChip capable of specifically binding metal interesting proteins. Proteomic spectra were generated by mass spectrometry. Bioinformatic calculations were performed with Biomarker Wizard software 3.0 (Ciphergen). Four differentially expressed potential biomarkers from urine were identified with the relative molecular weights of 4020, 4637, 5070, and 5500. The discriminatory classifier with a panel of the four biomarkers determined in the training set could precisely detect 24 of 30 (sensitivity, 80.0%) RCC and 52 of 58 (specificity, 89.6%) non-RCC samples. Furthermore, a sensitivity of 67.8% (19/28) and a specificity of 81.4% (35/43) for the blinded test were obtained when comparing the RCC vs. non-RCC. So SELDI-TOF combined with a tree analysis pattern could potentially serve as a useful tool for diagnosis of RCC by urine samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473487     DOI: 10.1177/153303460800700301

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  10 in total

1.  Effect of contact lenses on the protein composition in tear film: a ProteinChip study.

Authors:  Christina Kramann; Nils Boehm; Katrin Lorenz; Nelli Wehrwein; Bernhard M Stoffelns; Norbert Pfeiffer; Franz H Grus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-26       Impact factor: 3.117

Review 2.  Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.

Authors:  Steven L Wood; Margaret A Knowles; Douglas Thompson; Peter J Selby; Rosamonde E Banks
Journal:  Nat Rev Urol       Date:  2013-02-26       Impact factor: 14.432

Review 3.  Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.

Authors:  V Urquidi; C J Rosser; S Goodison
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 4.  Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics.

Authors:  Yi-Ting Chen; Cheng-Han Tsai; Chien-Lun Chen; Jau-Song Yu; Ying-Hsu Chang
Journal:  J Food Drug Anal       Date:  2018-10-27       Impact factor: 6.157

5.  Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model.

Authors:  Mindi Zhao; Menglin Li; Xundou Li; Chen Shao; Jianrui Yin; Youhe Gao
Journal:  Proteome Sci       Date:  2014-07-21       Impact factor: 2.480

Review 6.  Urinary Biomarkers of Brain Diseases.

Authors:  Manxia An; Youhe Gao
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-01-02       Impact factor: 7.691

7.  Evaluation of Protein Profiling in a Cohort of Egyptian Population with Renal Cell Carcinoma and Benign Kidney Neoplasms.

Authors:  Noha Said Kandil; Rasha Abdelmawla Ghazala; Rania Mohamed El Sharkawy; Tamer Abou Youssif; Noha Noha Abouseda
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

Review 8.  The cancer secretome: a reservoir of biomarkers.

Authors:  Hua Xue; Bingjian Lu; Maode Lai
Journal:  J Transl Med       Date:  2008-09-17       Impact factor: 5.531

9.  Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.

Authors:  Clizia Chinello; Marta Cazzaniga; Gabriele De Sio; Andrew James Smith; Erica Gianazza; Angelica Grasso; Francesco Rocco; Stefano Signorini; Marco Grasso; Silvano Bosari; Italo Zoppis; Mohammed Dakna; Yuri E M van der Burgt; Giancarlo Mauri; Fulvio Magni
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

Review 10.  Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers.

Authors:  Amir Taherkhani; Reyhaneh Farrokhi Yekta; Maede Mohseni; Massoud Saidijam; Afsaneh Arefi Oskouie
Journal:  Proteome Sci       Date:  2019-12-20       Impact factor: 2.480

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.